-+ 0.00%
-+ 0.00%
-+ 0.00%

GlucoTrack plans FDA IDE filing in Q2 2026; U.S. trial start expected in H2 2026 due to FDA review

Reuters·03/27/2026 12:26:07

Please log in to view news